Decreased Anticoagulant Effect of Warfarin: Periodically monitor prothrombin time/INR. (5.1) Risk of Aluminum Toxicity: For at risk patients (renal failure or those with prolonged therapy), periodically monitor aluminum levels with prolonged administration. (5.2)
•
Low Vitamin A levels: Monitor vitamin A levels. (5.3)